research aims to identify proteins in the urinary proteomes of normal controls, benign prostate hyperplasia (BPH) and prostate cancer by initial separation using SDS-PAGE followed by nanoLC-Orbitrap
million in 2013. Infections are of particular concern in diabetics. Benign prostatic hyperplasia and benign prostatic enlargement are the most common diseases in aging men which can lead to lower
Aberrant proliferation of prostate stem cells lead to Benign prostate hyperplasia (BPH) and prostate cancer (PCa) which are common prostatic disorders affecting elderly men. Hormonal imbalance, disruption of cell…
prostate is the site of two prevalent proliferative diseases in aging males, benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Etiologic causes are not well defined. While both diseases
prostate. Fifty nine biopsies were positive for adenocarcinoma prostate, 35 had benign prostate hyperplasia, one was prostatitis and five biopsies were inadequate. PSA levels were found high according to their
Kind prostatic hyperplasia (BPH), likewise called prostate amplification, is a noncancerous increment in size of the prostate gland.[1] Symptoms may incorporate incessant pee, inconvenience beginning to pee, powerless…
innovative Thermobalancing therapy with Dr Allen’s Device in people with kidney stones, benign prostatic hyperplasia (BPH), and chronic prostatitis / chronic pelvic pain syndrome (CP / CPPS) showed positive changes
Serum PSA levels are elevated in non-cancerous conditions including benign prostate hyperplasia (BPH) and acute prostatitis. Different isoforms of PSA have been discovered, including free PSA (fPSA), proPSA
authentic preventive guideline available which can prevent Prostate troubles like Prostatitis, Benign Prostatic hyperplasia and cancer of prostate. The treatment itself sometimes causes serious side effects like…
prostate conditions included 36 cases (13.4%) of prostate cancer, 48 cases (17.9%) of benign prostatic hyperplasia (BPH), 88 cases (32.8%) of prostatitis, while 99 (35.8%) were found normal. The highest
condition known as benign prostatic hyperplasia, which causes enlargement in the prostate gland and male pattern hair loss are both treated with a family of drugs known as 5 alpha
contents were prospectively evaluated in 32 patients with benign prostatic hyperplasia (BPH) and 36 patients with prostate cancer. Intact prostates of 37 men who had died suddenly were used
treated with testosterone replacement therapy. However, testosterone replacement may carry risk of cardiac hypertrophy, prostate hyperplasia and aggravate symptoms in men with prostate cancer. The objective of this study
Prostate artery embolization (PAE) is a new treatment option for men with benign prostatic hyperplasia (BPH), also known as an enlarged prostate gland. The procedure will help improve urinary symptoms
blocking medication that is approved by the US FDA to treat Benign Prostate Hyperplasia (BPH) by relaxing the muscles in the prostate and bladder neck, making it easier to urinate
epithelial cells of normal prostate, or in 100% of benign prostatic hyperplasia (BPH), but is expressed in >80% of prostatic intracellular neoplasia (PIN), high grade prostate cancers, and metastatic lesions
comparison with control cases. Methodology: A total of 50 patients of Benign Prostatic Hyperplasia (BPH) planned for Trans-Urethral Resection of Prostate (TURP) having a prostate size of more than
detection of PCa. The cohort included cases of PCa (n=112; 37.0%) and benign prostatic hyperplasia (BPH; n=191; 63.0%). The mean age, total prostate volume, tPSA, PSA (%), PSAD
contents were prospectively evaluated in 32 patients with benign prostatic hyperplasia (BPH) and 36 patients with adenocarcinoma (PCa). Intact prostates of 37 men who had died suddenly were used
increasing evidence that men with prostate cancer are associated with prostatitis and/or benign prostatic hyperplasia. Therefore, early and reliable diagnosis and treatment of prostatitis may reduce or even prevent
based selective α1-adrenoreceptor antagonists, which is usually used for the treatment of benign prostate hyperplasia (BPH) patients. Several evidences suggest that terazosin can induce apoptosis of prostatic cancer…
cell divisions, due to which the gland increases size, this leads to the benign prostate hyperplasia (BPH). Every organ in the human body consists of few common cells, similarly prostate
number of 241 subjects including 102 patients with PCa and 139 controls with benign prostatic hyperplasia (BPH). MMP1 and MMP2 genotypes were detected by RFLP.\ Results: Familial History of prostate
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.